LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancerQianfeng Shi, Qiang Liu|Nature Communications|2020Cited by 194
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitorsZijie Cai, Qiang Liu, Yudong Li et al.|Science China Life Sciences|2022Cited by 108